Paper31982192
Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors.
Bonhoure A and 8 others. Clin Nutr, 2020. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors. Papers, record 31982192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31982192
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiometabolic Risk Factors | Major topic |
| Cystic Fibrosis | Major topic |
| Lung | Major topic |
| Obesity | Major topic |
| Overweight | Major topic |
| Weight Gain | Major topic |
| Adolescent | |
| Adult | |
| Body Mass Index | |
| Comorbidity | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Respiratory Function Tests | |
| Young Adult |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941501 | Cardiovascular Manifestations of Cystic Fibrosis. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941501 | PubMed |
| 42332244 | Evaluation of the effect of CFTR modulator therapy on lipid profiles in children. | Pediatr Res | 2026 | https://conductscience.org/library/papers/42332244 | PubMed |
| 42199713 | Prevalence of overweight and obesity in a South Texas cystic fibrosis center. | J Clin Transl Endocrinol | 2026 | https://conductscience.org/library/papers/42199713 | PubMed |
| 41884126 | Joint associations of lung function of both general and abdominal obesity with cardiometabolic multimorbidity: a cross-sectional study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41884126 | PubMed |
| 41829925 | Prevalence of Overweight and Obesity in the Era of CFTR Modulators in Patients with Cystic Fibrosis. | Nutrients | 2026 | https://conductscience.org/library/papers/41829925 | PubMed |
| 41741006 | The impact of elexacaftor-tezacaftor-ivacaftor on cardiometabolic risk factors: a systematic review. | Eur Respir Rev | 2026 | https://conductscience.org/library/papers/41741006 | PubMed |
| 41709954 | Development of a Cystic Fibrosis Weight Management Programme: protocol for a co-design study. | NIHR Open Res | 2026 | https://conductscience.org/library/papers/41709954 | PubMed |
| 41622000 | Dietary recommendations for people with cystic fibrosis, a relevantly changing field. | J Pediatr (Rio J) | 2026 | https://conductscience.org/library/papers/41622000 | PubMed |
| 41117209 | Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review. | Endocr Connect | 2025 | https://conductscience.org/library/papers/41117209 | PubMed |
| 41010297 | Review of Disordered Eating Behaviors in Cystic Fibrosis. | Life (Basel) | 2025 | https://conductscience.org/library/papers/41010297 | PubMed |
| 40786988 | Glucagon-Like Peptide 1 Agonist Use in an Adult With Cystic Fibrosis-Related Diabetes and Metabolic Syndrome. | AACE Endocrinol Diabetes | 2025 | https://conductscience.org/library/papers/40786988 | PubMed |
| 40368427 | 20 years of the Montreal Cystic Fibrosis Related Diabetes Screening Cohort: key insights. | Eur Respir Rev | 2025 | https://conductscience.org/library/papers/40368427 | PubMed |
| 40248170 | Cholesterol and triglyceride concentrations following 12-18 months of clinically prescribed elexacaftor-tezacaftor-ivacaftor-PROMISE sub-study. | J Clin Transl Endocrinol | 2025 | https://conductscience.org/library/papers/40248170 | PubMed |
| 38449771 | The Changing Landscape of Treatment for Cystic Fibrosis Related Diabetes. | J Clin Transl Endocrinol | 2024 | https://conductscience.org/library/papers/38449771 | PubMed |
| 38140272 | Association between Dietary Intake and Faecal Microbiota in Children with Cystic Fibrosis. | Nutrients | 2023 | https://conductscience.org/library/papers/38140272 | PubMed |
| 37438197 | Changes in nutrition and growth status in young children in the first 12 weeks of ivacaftor therapy. | J Cyst Fibros | 2023 | https://conductscience.org/library/papers/37438197 | PubMed |
| 36967909 | CFTR High Expresser Cells in cystic fibrosis and intestinal diseases. | Heliyon | 2023 | https://conductscience.org/library/papers/36967909 | PubMed |
| 36678791 | Current and Future Therapeutic Approaches of Exocrine Pancreatic Insufficiency in Children with Cystic Fibrosis in the Era of Personalized Medicine. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36678791 | PubMed |
| 36678185 | Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention? | Nutrients | 2023 | https://conductscience.org/library/papers/36678185 | PubMed |
| 36573804 | Diet and the gut-lung axis in cystic fibrosis - direct & indirect links. | Gut Microbes | 2023 | https://conductscience.org/library/papers/36573804 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31982192
GET https://conductscience.org/api/papers/v1/31982192/cited_by?page=2